Biomedical Engineering Reference
In-Depth Information
34. Hiratsuka, S., et al.: MMP9 induction by vascular endothelial growth factor receptor-1 is
involved in lung-specific metastasis. Cancer Cell 2(4), 289-300 (2002)
35. Pepper, M.S., et al.: Vascular endothelial growth factor (VEGF) induces plasminogen
activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem.
Biophys. Res. Commun. 181(2), 902-906 (1991)
36. Hawinkels, L.J.A.C., et al.: VEGF release by MMP-9 mediated heparan sulphate cleavage
induces colorectal cancer angiogenesis. Eur. J. Cancer 44(13), 1904-1913 (2008)
37. Esser,
S.,
et
al.:
Vascular
endothelial
growth
factor
induces
VE-cadherin
tyrosine
phosphorylation in endothelial cells. J. Cell Sci. 111(13), 1853-1865 (1998)
38. Fleury, M.E., Boardman, K.C., Swartz, M.A.: Autologous morphogen gradients by subtle
interstitial flow and matrix interactions. Biophys. J. 91(1), 113-121 (2006)
39. Almqvist, N., et al.: Elasticity and adhesion force mapping reveals real-time clustering of
growth factor receptors and associated changes in local cellular rheological properties.
Biophys. J. 86(3), 1753-1762 (2004)
40. Kiosses, W.B., et al.: Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in
endothelial cell migration. Nat. Cell Biol. 3(3), 316-320 (2001)
41. Rousseau, S., et al.: p38 MAP kinase activation by vascular endothelial growth factor
mediates actin reorganization and cell migration in human endothelial cells. Oncogene
15(18), 2169-2177 (1997)
42. Podar, K., et al.: Caveolin-1 is required for vascular endothelial growth factor-triggered
multiple myeloma cell migration and is targeted by bortezomib. Cancer Res. 64(20),
7500-7506 (2004)
43. Caswell, P.T., Vadrevu, S., Norman, J.C.: Integrins: masters and slaves of endocytic
transport. Nat. Rev. Mol. Cell Biol. 10(12), 843-853 (2009)
44. Navarro, A., Anand-Apte, B., Parat, M.-O.: A role for caveolae in cell migration. FASEB J
18(15), 1801-1811 (2004)
45. Gerhardt, H., et al.: VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.
J. Cell Biol. 161(6), 1163-1177 (2003)
46. Pollock, A.S.: Matrix metalloproteinase 2(gelatinase A) regulates glomerular mesangial cell
proliferation and differentiation. J. Biol. Chem. 271(25), 15074-15083 (1996)
47. Iwamoto,
Y.,
et
al.:
YIGSR,
a
synthetic
laminin
pentapeptide,
inhibits
experimental
metastasis formation. Science 238(4830), 1132-1134 (1987)
48. Suchting, S., et al.: The notch ligand delta-like 4 negatively regulates endothelial tip cell
formation and vessel branching. Proc. Nat. Acad. Sci. U.S.A. 104(9), 3225-3230 (2007)
49. Yana, I., et al.: Crosstalk between neovessels and mural cells directs the site-specific
expression of MT1-MMP to endothelial tip cells. J. Cell Sci. 120(9), 1607-1614 (2007)
50. Ausprunk, D.H., Folkman, J.: Migration and proliferation of endothelial cells in preformed
and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14(1), 53-65
(1977)
51. Jakobsson, L., et al.: Endothelial cells dynamically compete for the tip cell position during
angiogenic sprouting. Nat. Cell Biol. 12(10), 943-953 (2010)
52. Funahashi, Y., et al.: Notch regulates the angiogenic response via induction of VEGFR-1.
J. Angiogenes. Res. 2(1), 3 (2010)
53. Krueger, J., et al.: Flt1 acts as a negative regulator of tip cell formation and branching
morphogenesis in the zebrafish embryo. Development 138(10), 2111-2120 (2011)
54. Cha, Y.R., Weinstein, B.M.: Visualization and experimental analysis of blood vessel
formation using transgenic zebrafish. Birth Defects Res. C 81(4), 286-296 (2007)
55. Ruhrberg, C., Gerhardt, H.: VEGF in Development, pp. 68-78. Springer, New York (2008)
56. Asahara, T., et al.: Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate
VEGF-induced postnatal neovascularization. Circ. Res. 83(3), 233-240 (1998)
57. Maisonpierre, P.C., et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo
angiogenesis. Science 277(5322), 55-60 (1997)
58. Das,
A.:
Angiopoietin/tek
interactions
regulate
MMP-9
expression
and
retinal
neovascularization. Lab. Invest. 83(11), 1637-1645 (2003)
Search WWH ::




Custom Search